QQ客服 官方微博 反馈留言

	Enediyne-activated, EGFR-targeted human beta-defensin 1 has therapeutic efficacy against non-small cell lung carcinoma
	Liu, Wen-juan; Zhu, Kun-li; Xu, Jian; Wang, Jia-lin; Zhu, Hui
刊名	LABORATORY INVESTIGATION
	2018
卷号	98期号:12页码:1538-1548
DOI	10.1038/s41374-018-0109-5
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4580894
专题	山东大学
作者单位	Shandong Univ, Shandong Acad Med Sci, Shandong Canc Hosp, Shandong Prov Key Lab Radiat Oncol,Shandong Canc, Jinan 25011
推荐引用方式 GB/T 7714	Liu, Wen-juan,Zhu, Kun-li,Xu, Jian,et al. Enediyne-activated, EGFR-targeted human beta-defensin 1 has therapeutic efficacy against non-small cell lung carcinoma[J]. LABORATORY INVESTIGATION,2018,98(12):1538-1548.
APA	Liu, Wen-juan,Zhu, Kun-li,Xu, Jian,Wang, Jia-lin,&Zhu, Hui.(2018).Enediyne-activated, EGFR-targeted human beta-defensin 1 has therapeutic efficacy against non-small cell lung carcinoma.LABORATORY INVESTIGATION,98(12),1538-1548.
MLA	Liu, Wen-juan,et al."Enediyne-activated, EGFR-targeted human beta-defensin 1 has therapeutic efficacy against non-small cell lung carcinoma".LABORATORY INVESTIGATION 98.12(2018):1538-1548.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。